| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.19 | 0.4 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.15 | 0.5 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.14 | 0.5 |